Added to YB: 2023-01-24
Pitch date: 2023-01-24
YMAb [bullish]
Y-mAbs Therapeutics, Inc.
+84.76%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of radioimmunotherapy and antibody based therapeutic products for the treatment of cancer.
Market Cap
$391.2M
Pitch Price
$4.66
Price Target
N/A
Dividend
N/A
EV/EBITDA
-19.73
P/E
-17.40
EV/Sales
3.89
Sector
Biotechnology
Category
N/A
Show full summary:
Y-mAbs Therapeutics, Inc YMAb
A summary for this pitch has not been created yet.
Read full article (0 min)